Equillium Bio (EQ): Balans kapitallashuviga qarzlar
Equillium, Inc. (EQ) aksiyalarining tebranishlari klinik sinovlar bosqichi va rahbariyat tomonidan joriy etilgan qat'iy xarajatlar nazorati bilan bog'liq. Qarzning kapitalizatsiyaga nisbati kredit yukini ko'rsatadi, bunda 0.01 ushbu metrikaning darajasini belgilaydi. Hamkorlik grantlari barqarorlikni ta'minlaydi, noyob immunomodulyatorlar uchun monopol narx belgilash imkoniyati istiqbollari esa kelajakdagi foyda o'sishi va bozor tebranishlarining yumshatilishiga va'da beradi.
equilliumbio.com (EQ) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning barcha koʻrsatkichlari tahlili:Equillium Bio EQ
Investorlar Equillium, Inc. (EQ) kompaniyasining barqarorligini kapitalga nisbatan qarz yuklamasini tahlil qilish orqali baholamoqdalar. Ushbu ko'rsatkich biznesning qarz mablag'lariga bog'liqlik darajasini aniqlash uchun umumiy majburiyatlarni aktivlarning balans qiymati bilan solishtiradi. Kredit yuzdalari — qarzning kitob kapitalizatsiyasiga nisbati — bo'yicha ushbu grafik retsessiya davrlarida bankrotlik xavflarini aniqlash imkonini beradi. Bioteknologiya sektori uchun qimmat filtratsiya tizimlari va ESG laboratoriya modernizatsiyalarini moliyalashtirishda past kredit yuzdalari juda muhimdir. Optimal qarz balansi texnologik rivojlanish sur'atlarini pasaytirmagan holda moliyaviy xavfsizlikni ta'minlaydi.
Equillium, Inc. kimlar bilan raqobatlashadi
argenx SE - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati biontech.de BNTX|ABIVAX - Balans kapitallashuviga qarzlar|ADMA Biologics Inc (ADMA) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Protagonist Therapeutics Inc PTGX|Immunovant Therapeutics (IMVT) - Qarzning sof aktivlarga nisbati|KNSA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar GRFS|Qarzning balans kapitallashuviga nisbati ADPT (Adaptive Biotechnologies Corporation)|Qarzning balans qiymatiga nisbati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma - Qarzning balans kapitallashuviga nisbati|BCRX - Qarzning balans qiymatiga nisbati|Vera Therapeutics, Inc. - Qarzning balans qiymatiga nisbati|DNTH: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Pharvaris|AbCellera Bio (ABCL) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar TRML (Tourmaline Corp)|Balans qiymatiga qarzlar Precigen Corp|Pharming Group N.V. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar NKTR (nektar.com)|UPB (Upstream Bio) - Qarzning balans kapitallashuviga nisbati|ZBIO - Qarzning sof aktivlarga nisbati|Immunome Corp - Qarzning balans qiymatiga nisbati|GOSS - Balans kapitallashuviga qarzlar|KalVista Pharmaceuticals - Balans kapitallashuviga qarzlar|SEPN (septerna.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Pieris Pharmaceuticals, Inc.|Qarzning balans kapitallashuviga nisbati SVRA|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|Qarzning balans kapitallashuviga nisbati AnaptysBio Inc. (ANAB)|Balans kapitallashuviga qarzlar ATXS|ENGN - Sof aktivlarga qarzlar|RAPT Therapeutics, Inc. - Qarzning balans qiymatiga nisbati|JBIO: Balans kapitallashuviga qarzlar|ACRS (Aclaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Kyverna Therapeutics, Inc|TLSA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati cabalettabio.com|VTYX (Ventyx Biosciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar THTX (Theratechnologies, Inc.)|AVTX - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Eledon Pharmaceuticals, Inc ELDN|AGEN: Balans kapitallashuviga qarzlar|climbbio.com (CLYM) - Qarzning balans qiymatiga nisbati|Zura Bio Limited - Qarzning balans qiymatiga nisbati|aTyr Pharma Inc (ATYR) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar ADAG (Adagene Inc)|Balans qiymatiga qarzlar IMA|STTK: Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CNTB (connectbiopharm.com)|Immunic (IMUX) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Atara Biotherapeutics, Inc. ATRA|Balans kapitallashuviga qarzlar InflaRx GmbH (IFRX)|XFOR - Qarzning sof aktivlarga nisbati|ACET: Balans kapitallashuviga qarzlar|CELU (Celularity) - Balans kapitallashuviga qarzlar|INMB - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati BRNS|Qarzning balans kapitallashuviga nisbati KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc (SABS)|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|ENLV - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Q32 Bio Corp (QTTB)|GOVX - Qarzning sof aktivlarga nisbati|Edesa - Balans kapitallashuviga qarzlar|IBIO (iBio Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CARM|Qarzning balans qiymatiga nisbati XTLB|Qarzning balans kapitallashuviga nisbati BOLT (Bolt Biotherapeutics)|Qarzning balans qiymatiga nisbati hcwbiologics.com HCWB|Qarzning balans qiymatiga nisbati APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Balans kapitallashuviga qarzlar|Aditxt Corp (ADTX) - Qarzning balans kapitallashuviga nisbati|GRI - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar XRTX|Vyome Holdings Inc. (HIND) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar REVB (Revelation Bio)|Balans qiymatiga qarzlar INDP|SCNI: Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati calcimedica.com CALI|Qarzning balans qiymatiga nisbati AFMD (Affimed N.V.)|Balans kapitallashuviga qarzlar Allakos Inc ALLK|Balans kapitallashuviga qarzlar HOOK (HOOKIPA)|IGMS: Sof aktivlarga qarzlar|iTeos Therapeutics (ITOS) - Qarzning balans kapitallashuviga nisbati|OCEA (oceanbiomedical.com) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati TC BioPharm|Qarzning balans kapitallashuviga nisbati Third Harmonic Bio Inc.